InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,168.00
(
0.52%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.15
(
0.02%
)
Bitcoin
66,751.92
(
0.17%
)
Post# of 252209
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

drbio45

Send PM Follow Ignore
Followers 36
Posts 3185
Boards Moderated 0
Alias Born 10/18/2003

drbio45

Re: DewDiligence post# 188029

Monday, 03/02/2015 6:22:38 PM

Monday, March 02, 2015 6:22:38 PM

Post# of 252209
As per my previous post if no one cares about whether a patient has a classic or occult lesion why is ophthotech excluding occult patients from their trials?

When Ohr released their interim data I bought a lot of stock on the open market even though they were a former client. I still own all of those shares.

I do currently do some consulting for them but I am posting as a shareholder.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up